Enterococcus spp. as a Producer and Target of Bacteriocins: A Double-Edged Sword in the Antimicrobial Resistance Crisis Context

• Published in: Antibiotics (Basel) Vol. 10; no. 10; p. 1215
• Main Authors: Almeida-Santos, Ana C., Novais, Carla, Peixe, Luísa, Freitas, Ana R.
• Format: Journal Article
• Language: English
• Published: Basel MDPI AG 07-10-2021; MDPI
• Subjects: alternatives to antibiotics; Antibiotic resistance; Antibiotics; Antimicrobial agents; Antimicrobial resistance; Bacteria; Bacterial infections; Bacteriocins; Competition; Drug resistance; Enterocins; enterococci; Enterococcus; Food industry; Genes; Global health; Gram-positive bacteria; Infections; Microbiota; Microorganisms; Multidrug resistance; multidrug-resistant infections; Pathogens; Peptides; Phylogeny; Plasmids; Probiotics; Review; Vancomycin
• ISSN: 2079-6382; 2079-6382
• DOI: 10.3390/antibiotics10101215

Enterococcus spp. are one of the most frequent producers of bacteriocins (enterocins), which provides them with an advantage to compete in their natural environment, which is the gut of humans and many animals. The enterocins’ activity against microorganisms from different phylogenetic groups has raised interest in Enterococcus spp. in different contexts throughout the last decades, especially in the food industry. Nevertheless, some species can also cause opportunistic life-threatening infections and are frequently multidrug-resistant (MDR). Vancomycin-resistant Enterococcus (VRE), in particular, are an ongoing global challenge given the lack of therapeutic options. In this scenario, bacteriocins can offer a potential solution to this persistent threat, either alone or in combination with other antimicrobials. There are a handful of studies that demonstrate the advantages and applications of bacteriocins, especially against VRE. The purpose of this review is to present a current standpoint about the dual role of Enterococcus spp., from important producers to targets needed to be controlled, and the crucial role that enterocins may have in the expansion of enterococcal populations. Classification and distribution of enterocins, the current knowledge about the bacteriocinome of clinical enterococci, and the challenges of bacteriocin use in the fight against VRE infections are particularly detailed.